ANTI-HSA-ANTIKÖRPER

European patent · EP3634997 · In force

Register entry

Publication number
EP3634997
Application number
EP18729642
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 4, 2018
Published
Apr 15, 2020
Granted
Feb 26, 2025
Protection ends at the latest
Jun 3, 2038
Next annual fee due
Jun 30, 2027
IPC classes
C07K 16/18 (2006.01)
C07K 16/24 (2006.01)
Priority
US 201762515293 P 05.06.2017
EP 17195783 10.10.2017
PCT application
PCT/EP2018/064622 04.06.2018
PCT publication
WO2018/224439 13.12.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jan 7, 2026

    Change

    Published in Swissreg on 07.01.2026

  3. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. Mar 5, 2025

    Owner

    Owner
    Numab Therapeutics AG, Einsiedlerstrasse 34, 8820 Wädenswil → Numab Therapeutics AG, Bachtobelstrasse 5, 8810 Horgen

    Published in Swissreg on 05.03.2025

  5. Mar 5, 2025

    Change

    Published in Swissreg on 05.03.2025

  6. Feb 26, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.02.2025

Parties

Holder

Numab Therapeutics AG

Bachtobelstrasse 5, 8810 Horgen

Inventor

GUNDE, Tea

8005 Zurich

MEYER, Sebastian

5445 Eggenwil

HESS, Christian

8045 Zurich

BIERI, Tessa

1110 Morges

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.